Azoles: Clinical Trials

5 trials of Azoles, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting, 1 recruiting, 1 terminated. 3 Phase 2, 3 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Recruiting 1
Phase 33Completed 2, Terminated 1
Phase 11Recruiting 1

Follow Azoles: new trials by email Literature Review of Azoles trials Research Report on Azoles

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Liposomal Amphotericin B for Invasive Fungal Disease in Solid Organ Transplant Recipients
Liposomal Amphotericin B, Alternative Systemic Antifungal Therapy - Invasive Fungal Infection, Solid Organ Transplantation
Not yet recruitingSichuan Provincial People's Hospital1202026-07-012026-06-24
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Enzomenib, azoles, Venetoclax - Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute
Phase 1 / Phase 2RecruitingSumitomo Pharma America, Inc.6062022-02-282026-03-24
Azole-echinocandin Combination Therapy for Invasive Aspergillosis
Azole, Anidulafungin - Invasive Aspergillosis
Phase 3TerminatedErasmus Medical Center662021-05-112024-05-07
A Randomized Trial of Itraconazole in Acute Stages of Allergic Bronchopulmonary Aspergillosis
Itraconazole, Glucocorticoids - Allergic Bronchopulmonary Aspergillosis
Phase 2 / Phase 3CompletedPost Graduate Institute of Medical Education and Research, Chandigarh1912014-05-012022-10-07
Monotherapy of Itraconazole Versus Prednisolone in Allergic Bronchopulmonary Aspergillosis
Glucocorticoids, Itraconazole - Allergic Bronchopulmonary Aspergillosis
Phase 2 / Phase 3CompletedPost Graduate Institute of Medical Education and Research, Chandigarh1002011-04-012017-03-16

Conditions studied

Aspergillosis, Allergic Bronchopulmonary (2)  ·  Invasive Fungal Infections (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Multiple Myeloma (1)  ·  Myelodysplastic Syndromes (1)  ·  Opportunistic Infections (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Recurrence (1)

Sponsors

Post Graduate Institute of Medical Education and Research, Chandigarh (2)  ·  Erasmus Medical Center (1)  ·  Sichuan Provincial People's Hospital (1)  ·  Sumitomo Pharma America, Inc. (1)

Countries

Belgium (2)  ·  India (2)  ·  Canada (1)  ·  China (1)  ·  France (1)  ·  Italy (1)  ·  Japan (1)  ·  Netherlands (1)  ·  Singapore (1)  ·  South Korea (1)  ·  Spain (1)  ·  Switzerland (1)  ·  Taiwan (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Bart Rijnders, MD, PhD (1)  ·  Lingai Pan, MD (1)  ·  Ritesh Agarwal, MD, DM (1)

Results publications

PMID 29331473, PMID 39378343